Ab Index-Nr. 607-316-00-3

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
607-316-00-3glyphosate-trimesium;
glyphosate-trimethylsulfonium
81591-81-3Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07 GHS09
Wng
H302
H411
   
607-317-00-9bis(2-ethylhexyl) phthalate;
di-(2-ethylhexyl) phthalate;
DEHP
204-211-0117-81-7Repr. 1BH360FDGHS08
Dgr
H360FD   
607-318-00-4dibutyl phthalate;
DBP
201-557-484-74-2Repr. 1B
Aquatic Acute 1
H360Df
H400
GHS08
GHS09
Dgr
H360Df
H400
   
607-319-00-Xdeltamethrin (ISO);
(S)-α-cyano-3-phenoxy­benzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-di­methylcyclo­propanecar­boxylate
258-256-652918-63-5Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410
 M = 1000000 
607-320-00-5bis[4-(ethenyloxy)butyl] 1,3-benzene­dicar­boxylate413-930-0130066-57-8Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
607-321-00-0(S)-methyl-2-chloropropionate412-470-873246-45-4Flam. Liq. 3
STOT RE 2 (*)
Eye Irrit. 2
H226
H373 (*)(*)
H319
GHS02
GHS08
Wng
H226
H373 (*)(*)
H319
   
607-322-00-64-(4,4-dimethyl-3-oxo-pyra­zolidin-1-yl)-benzoic acid413-120-7107144-30-9Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
607-323-00-12-(1-(2-hydroxy-3,5-di-tert-pen­tyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate413-850-6123968-25-2Aquatic Chronic 4H413H413   
607-324-00-7reaction mass of: N,N-di(hydrogenated alkyl
C14-C18)phtalamic acid;
dihydrogenated alkyl (C14-C18)amine
413-800-3Aquatic Chronic 4H413H413   
607-325-00-2(S)-2-chloropropionic acid411-150-529617-66-1Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
   
607-326-00-8reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethyl­non-2-enyl)succinate;
isobutyl hydrogen 2-(ß-2,4,6-trimetyhyl­non-2-enyl)succinate
410-720-0141847-13-4Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
607-327-00-32-(2-iodoethyl)-1,3-propanediol diacetate411-780-0127047-77-2Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
607-328-00-9methyl 4-bromo­methyl-3-me­thoxybenzoate410-310-170264-94-7Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
   
607-329-00-4reaction mass of: sodium 2-(C12-18–n-alkyl)ami­no-1,4-butan­dioate;
sodium 2-octadecenyl-amino-1,4-butan­dioate
411-250-9Skin Sens. 1H317GHS07
Wng
H317   
607-330-00-X(S)-2,3-dihydro-1H-indole-2-carboxylic acid410-860-279815-20-6Repr. 2
STOT RE 2 (*)
Skin Sens. 1
H361f
(*)(*)(*)
H373 (*)(*)
H317
GHS08
GHS07
Wng
H361f
(*)(*)(*)
H373 (*)(*)
H317
   
Folgender Eintrag wird ab 01.03.2018 gestrichen:
607-331-00-5
reaction mass of:
bis(2,2,6,6-tetramethyl-1-
octyloxypiperidin-4-yl)-1,10-decanedioate;
1,8-bis[(2,2,6,6-tetrame­thyl-
4-((2,2,6,6-tetramethyl-1-
oc­tyloxypiperidin-4-yl)-
de­can-1,10-dioyl)piperi­din-1-
yl)oxy]octane
406-750-9Aquatic Chronic 4H413H413   
607-332-00-0cyclopentyl chloroformate411-460-050715-28-1Flam. Liq. 3
Acute Tox. 3 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
H226
H331
H302
H373 (*)(*)
H318
H317
GHS02
GHS06
GHS08
GHS05
Dgr
H226
H331
H302
H373 (*)(*)
H318
H317
   
607-333-00-6reaction mass of: dodecyl N-(2,2,6,6-tetra­methyl­piperidin-4-yl)-β-alaninate;
tetradecyl N-(2,2,6,6-tetra­methyl­piperidin-4-yl)-β-alaninate
405-670-1Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 (*)(*)
H314
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 (*)(*)
H314
H410
   
607-334-00-1ethyl 1-ethyl-6,7,8-tri­fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate405-880-3100501-62-0Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
607-335-00-7methyl (R)-2-(4-(3-chloro-5-tri­fluorome­thyl-2-pyridy­loxy)phenoxy)propionate406-250-072619-32-0Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
607-336-00-24-methyl-8-methylenetri­cyclo[3.3.1.13,7]dec-2-yl acetate406-560-6122760-85-4Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Wng
H315
H317
H411
   
607-337-00-8di-tert-(C12-14)-alkylam­monium 2-benzo­thiazolylthio­succinate406-052-4125078-60-6Flam. Liq. 3
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H226
H302
H315
H318
H411
GHS02
GHS05
GHS07
GHS09
Dgr
H226
H302
H315
H318
H411
   
607-338-00-32-methylpropyl 2-hydroxy-2-methylbut-3-enoate406-235-972531-53-4Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Wng
H319
H315
   
607-339-00-92,3,4,5-tetrachlorobenzoyl­chloride406-760-342221-52-3Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Dgr
H302
H314
H317
   
607-340-00-41,3-bis(4-benzoyl-3-hydroxy­phenoxy)prop-2-yl acetate406-990-4Aquatic Chronic 2H411GHS09H411   
607-341-00-X(9S)-9-amino-9-deoxyerythro­mycin406-790-726116-56-3Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
   
607-342-00-54-chlorobutyl veratrate410-950-169788-75-6Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-343-00-04,7-methanooctahydro-1H-in­dene-diyldimethyl bis(2-carboxybenzoate)407-410-2Aquatic Chronic 4H413H413   
607-344-00-6reaction mass of: 3-(N-(3-dimethylamino­propyl)-(C4-8)perfluoroalkyl­sulfonamido)propionic acid;
N-[dimethyl-3-(C4-8-perfluoro­alkylsulfonamido)propylam­monium propionate;
3-(N-(3-dimethyl-propylam­monium)-(C4-8)perfluoroalkyl­sulfonamido)propionic acid propionate
407-810-7STOT RE 2 (*)H373 (*)(*)GHS08
Wng
H373 (*)(*)   
607-345-00-1potassium 2-(2,4-dichloro­phenoxy)-(R)-propio­nate413-580-9113963-87-4Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317
   
607-346-00-73-icosyl-4-henicosy­lidene-2-oxetanone401-210-983708-14-9Aquatic Chronic 4H413H413   
607-347-00-2sodium (R)-2-(2,4-di­chloro­phenoxy)propionate413-340-3119299-10-4Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317
   
607-348-00-8magnesium bis((R)-2-(2,4-di­chloro­phe­noxy)pro­pionate)413-360-2Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317
   
607-349-00-3mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate411-270-8Aquatic Chronic 3H412 H412   
607-350-00-9bis(4-(1,2-bis(ethoxycarbo­nyl)ethylamino)-3-methyl­cyclohexyl)methane412-060-9136210-32-7Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
607-351-00-4methyl O-(4-amino-3,5-dichloro-6-fluoro­pyridin-2-yloxy)acetate407-550-469184-17-4Aquatic Chronic 2H411GHS09H411   
607-352-00-X4,4'-oxydiphthalic anhydride412-830-41823-59-2Aquatic Chronic 3H412H412   
607-353-00-5reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate;
ethyl endo-tri­cyc­lo[5.2.1.02,6]decane-exo-2-car­boxylate
407-520-080657-64-3Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
607-354-00-0ethyl 2-cyclohexylpropionate412-280-52511-00-4Aquatic Chronic 2H411GHS09H411   
607-355-00-6p-tolyl 4-chlorobenzoate411-530-015024-10-9Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
607-356-00-1ethyl trans-2,2,6-tri­methyl­cyclo­hexanecar­boxylate412-540-8Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
607-357-00-7reaction mass of: trans-4-acetoxy-4-methyl-
2-propyl-tetrahydro-2H-pyran;
cis-4-acetoxy-4-methyl-2-pro­pyl-tetrahydro-2H-pyran
412-450-9131766-73-9Skin Sens. 1H317GHS07
Wng
H317   
607-358-00-2(1S,3S,5R,6R)-(4-nitrophenyl­methyl)-1-dioxo-6-phenyl­acetamido-penam-3-carboxylate412-670-554275-93-3Resp. Sens. 1H334GHS08
Dgr
H334   
607-359-00-8(1S,4R,6R,7R)-(4-nitrophenyl­methyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-car­boxylateido-penam-3-car­boxylate412-800-076109-32-5Resp. Sens. 1H334GHS08
Dgr
H334   
607-360-00-3sodium 3-acetoace­tylami­no-4-methoxy­tolyl-6-sulfo­nate411-680-7133167-77-8Skin Sens. 1H317GHS07
Wng
H317   
607-361-00-9methyl (R)-2-(4-hydroxy­phenoxy)pro­pionate411-950-496562-58-2Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
607-362-00-4reaction mass of: (3-methoxy)propylammo-
nium/[tris-(2-hydroxyethyl)]am­monium 2-(2-(bis(2-hydroxyethyl)ami­no)ethoxycarbo-nylmethyl)he­xadec-4-enoate;
(3-methoxy)propylammo­nium/[tris-(2-hydroxyethyl)]am­monium 2-(2-(bis(2-hydroxye­thyl)amino)ethoxycarbonyl­methyl)tetradec-4-enoate;
(3-methoxy)propylam­monium/[tris-(2-hydroxy­ethyl)]ammo­nium 2-(3-methoxy­propyl­carba­moyl­methyl)hexadec-4-enoate;
(3-methoxy)propylam­mo­nium/[tris-(2-hydroxyethyl)]am­monium 2-(3-methoxy­propyl­carbamoyl­methyl)tetradec-4-enoate
413-500-2Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H315
H318
H411
GHS05
GHS09
Dgr
H315
H318
H411
   
607-363-00-Xmethyl-3-methoxyacrylate412-900-45788-17-0Skin Sens. 1H317GHS07
Wng
H317   
607-364-00-53-phenyl-7-[4-(tetrahydrofur­furyloxy)phenyl]-1,5-dioxa-s-in­dacen-2,6-dione413-330-9134724-55-3Aquatic Chronic 4H413 H413   
607-365-00-02-(2-amino-1,3-thiazol-4-yl)-(Z)-
2-methoxyiminoacetyl chloride hydrochloride
410-620-7119154-86-8Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Dgr
H302
H314
H317
   
607-366-00-63,5-dimethylbenzoyl chloride413-010-96613-44-1Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317
   
607-367-00-1potassium bis(N-car­boxy­methyl)-N-methyl-glyci­nato-(2-)N,O,O,N)-ferrate-(1-) monohydrate411-640-9153352-59-1Acute Tox. 4 (*)H302GHS07
Wng
H302   
607-368-00-71-(N,N-dimethylcarba­moyl)-3-tert-butyl-5-carbethoxy­methylthio-1H-1,2,4-triazole411-650-3110895-43-7Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410
   
607-369-00-2reaction mass of: trans-(2R)-5-acetoxy-1,3-oxa­thiolane-2-carboxylic acid;
cis-(2R)-5-acetoxy-1,3-oxa­thiolane-2-carboxylic acid
411-660-8147027-04-1Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317
   
607-370-00-82-[[2-(acetyloxy)-3-(1,1-di­methyl-ethyl)-5-methylphe­nyl]methyl]-6-(1,1-dimethyl­ethyl)-4-methylphenol412-210-341620-33-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-371-00-33-ethyl 5-methyl 4-(2-chloro­phenyl)-1,4-di­hydro-2-[2-(1,3-di­hydro-1,3-di­oxo-(2H)isoin­dol-2-yl)-ethoxy­methyl]-6-methyl-3,5-pyri­dinedicar­boxylate413-410-388150-62-3Aquatic Chronic 4H413H413   
607-372-00-9ethoxylated bis phenol A di-(norbornene
carboxylate)
412-410-0Aquatic Chronic 3H412H412   
607-373-00-4(±) tetrahydrofurfuryl (R)-2-[4-(6-chloroqui­noxa­lin-2-yloxy)phe­nylo­xy]propionate414-200-4119738-06-6Muta. 2
Repr. 1B
Acute Tox. 4 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H341
H360-
Df
H302
H373 (*)(*)
H400
H410
GHS08
GHS07
GHS09
Dgr
H341
H360Df
H302
H373 (*)(*)
H410
   
607-374-00-X5-amino-2,4,6-triiodo-1,3-ben­zenedi­carbonyl­dichloride417-220-137441-29-5Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
bis 28.02.2018
607-375-00-5
reaction mass of: cis-4-hy­droxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoro­methylben­zyloxy)phe­nyl)-1-naphthyl)coumarin;
trans-4-hydroxy-3-(1,2,3,4-te­trahydro-3-(4-(4-trifluoro­methylbenzyloxy)phenyl)-1-naph­thyl)coumarin
421-960-090035-08-8Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H372 (*)(*)
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H372 (*)(*)
H410
   
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
607-375-00-5
Flocoumafen (ISO);
Reaktionsmasse aus:
cis-4-Hydroxy-3-
(1,2,3,4-tetrahydro-3-
(4-(4-trifluormethylben-
zyloxy)phenyl)-1-naph-
thyl)cumarin und trans-
4-Hydroxy-3-(1,2,3,4-
tetrahydro-3-(4-(4-tri-
fluormethylbenzyloxy)
phenyl)-1-naphthyl)cu-
marin
421-960-090035-08-8Repr. 1B
Acute Tox. 1
Acute Tox. 1
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H360D
H330
H310
H300
H372 (Blut)
H400
H410
GHS08
GHS06
GHS09
Dgr
H360D
H330
H310
H300
H372 (Blut)
H410
 Repr. 1B; H360D:
C ≥ 0,003 %
STOT RE 1; H372 (Blut):
C ≥ 0,05 %
STOT RE 2; H373 (Blut):
0,005 % ≤ C < 0,05 %
M = 10
M = 10
 
607-376-00-0benzyl 2,4-dibromobutanoate420-710-823085-60-1Repr. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f
(*)(*)(*)
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f
(*)(*)(*)
H315
H317
H410
   
607-377-00-6trans-4-cyclohexyl-L-proline monohydrochloride419-160-190657-55-9Repr. 2
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H361f
(*)(*)(*)
H302
H315
H318
H317
GHS08
GHS05
GHS07
Dgr
H361f
(*)(*)(*)
H302
H315
H318
H317
   
607-378-00-1ammonium (Z)-α-me­thoxyimi­no-2-furyla-cetate405-990-197148-39-5Flam. Sol. 2H228GHS02
Dgr
H228  T
607-379-00-7reaction mass of: 2-[N-(2-hydroxyethyl)
stearamido]ethyl stearate;
sodium [bis[2-(stea­royloxy)ethyl]ami­no]methyl­sulfonate;
sodium [bis(2-hy­droxy­ethyl)amino]methyl­sulfonate;
N,N-bis(2-hydroxyethyl)stea­ramide
401-230-8 Aquatic Chronic 3H412H412   
607-380-00-2reaction mass of: ammonium-1,2-bis(hexy-
loxycarbonyl)ethanesulfonate;
ammonium-1-hexyloxycarbonyl-2-octyloxy-
carbonylethanesulfonate;
ammonium-2-hexyloxycarbonyl-1-octyloxy-
carbonylethanesulfonate
407-320-3Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
   
607-381-00-8reaction mass of triesters of 2,2-bis(hydro-
xymethyl)butanol with C7-alkanoic acids
and 2-ethylhexanoic acid
413-710-4Aquatic Chronic 4H413H413   
607-382-00-32-((4-amino-2-nitrophenyl)ami-
no)benzoic acid
411-260-3117907-43-4Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
607-383-00-9reaction mass of: 2,2,6,6-tetramethylpiperi-
din-4-yl-hexadecanoate;
2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate
415-430-886403-32-9Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410
   
607-384-00-4reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid;
C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-
hydroxybenzenepropanoate;
C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-
hydroxybenzenepropanoate
413-750-2171090-93-0Aquatic Chronic 4H413H413   
607-385-00-XCopolymer of vinyl-alcohol and vinyl acetate
partially acetilized with 4-(2-(4-formylphe-
nyl)ethenyl)-1-methylpyridinium methylsulfate
414-590-6125229-74-5Aquatic Chronic 2H411GHS09H411   
607-386-00-5reaction mass of: tetradecanoic acid (42,5-
47,5 %);
poly(1-7)lactate esters of tetradecanoic acid
(52,5- 57,5 %)
412-580-6174591-51-6Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
   
607-387-00-0reaction mass of: dodecanoic acid (35-40 %);
poly(1-7)lactate esters of dodecanoic acid
(60-65 %)
412-590-058856-63-6Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
   
607-388-00-64-ethylamino-3-nitrobenzoic acid412-090-22788-74-1Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
   
607-389-00-1trisodium N,N-bis(carboxy­methyl)-3-amino-2-hydroxypropionate414-130-4119710-96-2Acute Tox. 4 (*)H302GHS07
Wng
H302   
607-390-00-71,2,3,4-tetrahydro-6-nitro-quinoxaline414-270-641959-35-7Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
607-391-00-2dimethylcyclopropane-1,1-di­carboxylate414-240-26914-71-2Aquatic Chronic 3H412H412   
607-392-00-82-phenoxyethyl 4-((5-cyano-1,6-di­hydro-2-hydroxy-1,4-di­methyl-6-oxo-3-pyridi­nyl)azo)benzoate414-260-188938-37-8Aquatic Chronic 4H413H413   
607-393-00-33-(cis-1-propenyl)-7-ami­no-8-oxo-5-thia-1-azabicyc­lo[4.2.0]oct-2-ene-2-carboxy­lic acid415-750-8106447-44-3Skin Sens. 1H317GHS07
Wng
H317   
607-394-00-95-methylpyrazine-2-car­boxylic acid413-260-95521-55-1Eye Dam. 1H318GHS05
Dgr
H318   
607-395-00-4reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfo­butanedioate;
sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobu-tanedioate
410-230-7Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411
   
607-396-00-Xbis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxy­benzyli­dene)malo­nate414-840-4147783-69-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-397-00-5reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated);
Ca phenates (branched C10-14 and C18-30 alkylated);
Ca sulfurised phenates (branched C10-14 and C18-30 alkylated)
415-930-6Repr. 2
Skin Sens. 1
H361f ***
H317
GHS08
GHS07
Wng
H361f ***
H317
   
607-398-00-0ethyl N-(5-chloro-3-(4-(diethylamino)-2-
methylphenylimino)-4-methyl-6-oxo-1,4-
cyclohexadienyl)carbamate
414-820-5125630-94-6Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-399-00-62,2-dimethyl 3-methyl-3-butenyl propanoate415-610-6104468-21-5Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
   
607-400-00-Xmethyl 3-[[(dibutylamino)thioxomethyl]
thio]propanoate
414-400-132750-89-3Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-401-00-5ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate414-450-488805-65-6Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H315
H318
H317
GHS05
GHS07
Dgr
H315
H318
H317
   
607-402-00-0methyl N-(phenoxycarbonyl)-L-valinate414-500-5153441-77-1Aquatic Chronic 3H412H412   
607-403-00-6reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;
isopropyl alcohol
414-810-0STOT RE 2 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 (*)(*)
H318
H400
H410
GHS08
GHS05
GHS09
Dgr
H373 (*)(*)
H318
H410
   
607-404-00-1reaction mass of: ((Z)-3,7-dimethyl-2,6-octa­dienyl)oxycarbonyl­propanoic acid;
di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;
di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;
(Z)-3,7-dimethyl-2,6-octadienyl butandioate;
((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid
415-190-4Skin Sens. 1H317GHS07
Wng
H317   
607-405-00-72-hexyldecyl-p-hydroxy­benzoate415-380-7148348-12-3Aquatic Chronic 2H411GHS09H411   
607-406-00-2potassium 2,5-dichlorobenzoate415-700-5184637-62-5Acute Tox. 4 (*)
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
   
607-407-00-8ethyl 2-carboxy-3-(2-thienyl)pro­pionate415-680-8143468-96-6Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H315
H318
H317
GHS05
GHS07
Dgr
H315
H318
H317
   
607-408-00-3potassium N-(4-fluorophe­nyl)glycinate415-710-1184637-63-6STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H373 (*)(*)
H318
H317
H412
GHS08
GHS05
GHS07
Dgr
H373 (*)(*)
H318
H317
H412
   
607-409-00-9reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;
inert biomass from Aspergillus terreus
415-840-7Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
607-410-00-4mono[2-(dimethylami­no)ethyl]monohydro-gen-2-(hexa­dec-2-enyl)butanedioate and/or mono[2-(dimethylami­no)ethyl]monohydrogen-3-(hexa­dec-2-enyl)butanedioate415-880-5779343-34-9Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
   
607-411-00-Xoxiranemethanol, 4-methylbenzene-sulfonate, (S)-417-210-770987-78-9Carc. 1B
Muta. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H350
H341
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H350
H341
H318
H317
H411
   
607-412-00-5ethyl 2-(1-cyanocyclohexyl)acetate415-970-4133481-10-4Acute Tox. 4 (*)
STOT RE 2 (*)
Aquatic Chronic 3
H302
H373 (*)(*)
H412
GHS08
GHS07
Wng
H302
H373 (*)(*)
H412
   
607-413-00-0trans-4-phenyl-L-proline416-020-196314-26-0Repr. 2
Skin Sens. 1
H361f
(*)(*)(*)
H317
GHS08
GHS07
Wng
H361f
(*)(*)(*)
H317